1. Guía Mexicana de Práctica Clínica de Inmunoterapia 2011.
- Author
-
Larenas-Linnemann, Désirée, Ortega-Martell, José Antonio, del Río-Navarro, Blanca, Rodríguez-Pérez, Noel, Arias-Cruz, Alfredo, Estrada, Alan, Becerril-Ángeles, Martín, Pietropaolo-Cienfuegos, Dino R., de Jesús Ambriz-Moreno, Maria, Báez-Loyola, Carlos, Cossío-Ochoa, Enna, González-Díaz, Sandra Nora, Hidalgo-Castro, Emilia María, Huerta-Hernández, Rosa Elena, Macías-Weinmann, Alejandra, Oyoqui-Flores, Joel, Stone-Aguilar, Héctor, Belinda Treviño-Salinas, Marisol, and del Carmen Zárate-Hernández, María
- Subjects
- *
PHYSICIAN practice patterns , *IMMUNOTHERAPY , *ALLERGIES , *SKIN tests , *ALLERGENS , *RHINITIS , *ATOPIC dermatitis , *PATIENTS , *THERAPEUTICS - Abstract
Background: Several international guidelines on immunotherapy exist, but they only apply partially in Mexico. The Mexican guideline of immunotherapy dates from 1998. Objectives: To establish clinical recommendations and suggestions for Allergy residents and specialists for skin testing and allergen immunotherapy based on evidence and Mexican expert opinion, according to the GRADE system. Methods: The guidelines were developed following the methodology of a guideline for clinical practice starting with the formulation of clinical questions, in the context of Mexican environmental conditions and morbidity, with the participation of allergists from all regions of the country. External validation was obtained. Its development followed three steps: 1. formulation of 24 clinical questions. 2. Search for consensus on the answers among members of the Regional chapters of both Mexican Colleges of Allergists (CMICA and COMPEDIA) during regional meetings. 3. Literature search for articles related to the questions and grading of its quality according to GRADE. Results: Based on the regional consensus, 116 articles and the safety, patient acceptance/ comfort and cost clinical recommendations and suggestions were developed on basic aspects of skin testing, subcutaneous and sublingual immunotherapy (patient preparation, vial preparation and application schedules) and the treatment of eventual adverse reactions. Conclusions: A clinical guideline was developed respecting particular methodology, validated by CMICA and COMPEDIA for its implementation among Mexican allergists. Several aspects deserve further study to improve scientific evidence. [ABSTRACT FROM AUTHOR]
- Published
- 2011